Clinical Nuclear Medicine · 2017 · 15 citations · 13 references
MedicineOncologyRadiologyDiagnostic ImagingDiagnostic RadiologyGenitourinary RadiologyProstate CancerProstate Cancer ImagingProstate ImagingProstatic PathologyTumor CharacterizationTumor MarkersHistopathologic InterpretationProstate Cancer DiagnosisProstate Cancer HistopathologyProstate Tumor MarkersProstate-specific Membrane Antigen PetProstate-specific Membrane Antigen Positron Emission TomographyProstate-specific Membrane Antigen RadioligandsPsma-pet Imaging
Prostate-specific membrane antigen (PSMA) is a typ. 2 transmembrane protein that is highly expressed in prostate cancer cells. Ga-PSMA PET/CT imaging is a modality used to determine the extent of prostate cancer. Various other neoplasias may also express PSMA, which appears as Ga-PSMA uptake in PET/CT imaging. A 71-year-old man with prostate cancer underwent Ga-PSMA PET/CT imaging for restaging after having an elevated prostate-specific antigen level. Subcutaneous lesions showing focal PSMA uptake were detected, one of which was excised. The histopathologic diagnosis was dermatofibroma.
13
Prostate-specific membrane antigen expression in normal and malignant human tissues.
Donald Silver, I Pellicer, W R Fair et al. · PubMed · 1997 · 1.5K citations
Ali Afshar‐Oromieh, Eleni Avtzi, Frederik L. Giesel et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2014 · 974 citations · Full text
Medicine, Nuclear Medicine, Oncology +17
Ali Afshar‐Oromieh, Christian M. Zechmann, A. Malcher et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2013 · 928 citations · Full text